Caredx Inc (NASDAQ: CDNA) has seen a rise in its stock price by 2.44 in relation to its previous close of 18.42. However, the company has experienced a 4.02% gain in its stock price over the last five trading sessions. prnewswire.com reported 2024-07-16 that NEW YORK, July 16, 2024 /PRNewswire/ — Purcell & Lefkowitz LLP announces that it is investigating CareDx, Inc. (NASDAQ: CDNA) on behalf of the company’s shareholders. The investigation seeks to determine whether CareDx’s directors breached their fiduciary duties in connection with recent corporate actions.
Is It Worth Investing in Caredx Inc (NASDAQ: CDNA) Right Now?
Moreover, the 36-month beta value for CDNA is 1.76. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for CDNA is 48.74M and currently, short sellers hold a 8.04% of that float. On July 26, 2024, CDNA’s average trading volume was 813.62K shares.
CDNA’s Market Performance
CDNA’s stock has seen a 4.02% increase for the week, with a 29.16% rise in the past month and a 136.47% gain in the past quarter. The volatility ratio for the week is 6.74%, and the volatility levels for the past 30 days are at 7.11% for Caredx Inc The simple moving average for the last 20 days is 15.60% for CDNA stock, with a simple moving average of 76.11% for the last 200 days.
Analysts’ Opinion of CDNA
Craig Hallum, on the other hand, stated in their research note that they expect to see CDNA reach a price target of $15. The rating they have provided for CDNA stocks is “Buy” according to the report published on May 01st, 2024.
Stephens gave a rating of “Overweight” to CDNA, setting the target price at $10 in the report published on November 09th of the previous year.
CDNA Trading at 23.04% from the 50-Day Moving Average
After a stumble in the market that brought CDNA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -3.63% of loss for the given period.
Volatility was left at 7.11%, however, over the last 30 days, the volatility rate increased by 6.74%, as shares surge +34.69% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +25.97% upper at present.
During the last 5 trading sessions, CDNA rose by +4.02%, which changed the moving average for the period of 200-days by +189.86% in comparison to the 20-day moving average, which settled at $16.57. In addition, Caredx Inc saw 57.25% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CDNA starting from Seeto Reginald, who sale 2,818 shares at the price of $6.91 back on Oct 02 ’23. After this action, Seeto Reginald now owns 479,164 shares of Caredx Inc, valued at $19,483 using the latest closing price.
Seeto Reginald, the of Caredx Inc, sale 2,819 shares at $9.49 during a trade that took place back on Sep 05 ’23, which means that Seeto Reginald is holding 481,982 shares at $26,762 based on the most recent closing price.
Stock Fundamentals for CDNA
Current profitability levels for the company are sitting at:
- -0.36 for the present operating margin
- 0.62 for the gross margin
The net margin for Caredx Inc stands at -0.67. The total capital return value is set at -0.26. Equity return is now at value -54.18, with -37.36 for asset returns.
Based on Caredx Inc (CDNA), the company’s capital structure generated 0.11 points at debt to capital in total, while cash flow to debt ratio is standing at -1.04.
Currently, EBITDA for the company is -82.08 million with net debt to EBITDA at 0.76. When we switch over and look at the enterprise to sales, we see a ratio of 3.35. The receivables turnover for the company is 4.57for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.32.
Conclusion
To wrap up, the performance of Caredx Inc (CDNA) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
